EMVision Medical Devices Receives Milestone Payment for Second-Generation Brain Scanner for First Responders

EMVision is developing a second-generation handheld brain scanner for first responders to quickly diagnose stroke patients.

EMVision Medical Devices (ASX:EMV) has received a $600,000 payment after achieving a “significant milestone” for its second-generation stroke detection device for first responders.

The payment comes from the Australian Stroke Alliance, under the Commonwealth of Australia Medical Research Future Fund programme.

Under a project agreement with the Australian Stroke Alliance, EMVision will receive $8 million in installment payments over a five-year period.

To date, EMVision has received $1.8 million with $6.2 million remaining.

In securing the final payment of $600,000, EMVision’s milestone activities include collecting detailed data on end-user requirements.

This has included workshops with VIC Ambulance, NSW Ambulance and the Royal Flying Doctor Service.

These activities aim to ensure that the second generation stroke detection scanner for first responders is easy to use and can be integrated seamlessly into clinical workflows.

Leverage first-generation hospital scanning technology

EMVision’s second generation device leverages the core technology of the first generation hospital bedside scanner.

The proposed head design for the second-generation first responder scanner includes a hybrid antenna array, proprietary coupling cap, and integrated neck, head, and shoulder support.

EMVision chief executive Dr Ron Weinberger said the company has made “significant progress” on the second-generation device, while working in parallel to refine its first-generation hospital scanner.

“The extensive work done by our team will ensure that the device is fit for purpose and meets all end-user needs – an essential part of the design process.”

Dr Weinberger added that there would be further updates on both devices as more milestones are reached in the “short term”.

Government funding

In addition to the $8 million grant from the Australian Stroke Alliance, EMVision announced last month that it had secured $5 million in funding under the Australian Federal Government’s Modern Manufacturing Initiative (MMI).

The grant will help EMVision establish commercial-scale manufacturing capabilities so it can sell its units once regulatory approvals are obtained.

EMVision expects the $5 million funding to help establish a local manufacturing base in New South Wales.


Source link

Elaine R. Knight